Fundraising Fox

DOSE Therapeutics

Dallas, US · Founded 2021 · Delaware corporation

Biotech

Founders & leadership

MT
McHenry T. TichenorNamed on SEC filing
SL
Steven L. McknightNamed on SEC filing
MB
Michael BakesNamed on SEC filing
BL
Blair LapointeNamed on SEC filing
JF
John Fulton MurrayNamed on SEC filing
DN
Deepak NijhawanNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2022

▶$10MraisedMay 2022 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • McHenry T. TichenorDirector
  • Steven L. McknightDirector
  • Michael BakesExecutive Officer
  • Blair LapointeDirector
  • John Fulton MurrayExecutive Officer, Director
  • Deepak NijhawanDirector
Offering amount
$10M
Amount sold
$10M
Proceeds to insiders
$380K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has DOSE Therapeutics raised?
DOSE Therapeutics has disclosed $10M raised across 1 round.
Where is DOSE Therapeutics headquartered?
DOSE Therapeutics is headquartered in Dallas, US.